ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,708.60
3.40 (0.20%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.40 0.20% 1,708.60 1,708.60 1,708.80 1,713.00 1,699.40 1,701.60 11,522,668 16:29:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.27 70.34B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,705.20p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £70.34 billion. Gsk has a price to earnings ratio (PE ratio) of 14.27.

Gsk Share Discussion Threads

Showing 29926 to 29947 of 33075 messages
Chat Pages: Latest  1203  1202  1201  1200  1199  1198  1197  1196  1195  1194  1193  1192  Older
DateSubjectAuthorDiscuss
06/6/2022
11:41
Trying to understand how it can be in Pfizer's interest to announce before the float that they are going to dispose of their third of Haleon at the earliest opportunity. Although they will be forced to wait a few months, this must have a significant effect on the initial price. Not so?
jonjoneil
06/6/2022
11:40
It'll just be nodded through.
keyno
06/6/2022
11:32
It's 467 pages! But most of it is of little interest to the likes of us.
anhar
06/6/2022
11:30
Great thanks I'll read the propectus all ways a good idea?
jretlaw
06/6/2022
11:26
The date has been given in the prospectus timetable on page 16, extract:

...Latest time and date for transfers of GSK Shares to be
registered on the Register at the Shareholder Record Time 6 p.m. on 15 July 2022

Shareholder Record Time for determining the entitlement to the Demerger Dividend
6 p.m. on 15 July 2022...

This assumes all the shareholder etc. formalities and perrmissions are granted according to the timetable for the demerger to take place, it being almost certain that they will.

hxxps://www.gsk.com/media/7702/haleon-plc-prospectus.pdf

anhar
06/6/2022
10:05
GSK wins FDA approval for measles, mumps and rubella vaccine Priorix

Mon, 6th Jun 2022 10:05
Alliance News

(Alliance News) - GSK PLC on Monday said the US Food & Drug Administration has approved its Priorix vaccine for active immunisation for the prevention of measles, mumps and rubella

in individuals of 12 months of age and older.

The London-based pharmaceutical company said Priorix is currently licenced in more than 100 countries worldwide, including all European countries, Canada, Australia and New Zealand.

More than 800 million doses of the treatment have been distributed to date, the FTSE 100 listed firm added.

The safety of Priorix was evaluated in six clinical studies, in which a total of 12,151 participants received at least one dose of it. Its efficacy was demonstrated based on immunogenicity data compared to the comparator vaccine.

Measles, mumps and rubella are acute and contagious viral diseases that can also lead to serious conditions including meningitis and hearing loss.

"We're proud to make Priorix available in the US for the first time, adding a choice for providers to help protect patients against these highly contagious diseases and to further strengthen offerings in our paediatric vaccine portfolio," said Judy Stewart, head of US Vaccines for GSK.


By Abby Amoakuh; abbyamoakuh@alliancenews.com

waldron
06/6/2022
08:57
For news on Haleon (HAL), I think its best to wait for the Shareholders to vote at the General Meeting on 6 July.
tradermichael
06/6/2022
08:08
Will the be an ex split date at which date we will get the entitlement to hallion
jretlaw
06/6/2022
08:06
Will there be a ex split date at which one has to hold the shares upto to get halion as no mention so far in the littrature
jretlaw
06/6/2022
06:48
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Priorix (Measles, Mumps and Rubella Vaccine, Live) for active immunisation for the prevention of measles, mumps and rubella (MMR) in individuals 12 months of age and older.

Priorix is currently licenced in more than 100 countries worldwide, including all European countries, Canada, Australia and New Zealand, with more than 800 million doses distributed to date.

"We're proud to make Priorix available in the US for the first time, adding a choice for providers to help protect patients against these highly-contagious diseases and to further strengthen offerings in our paediatric vaccine portfolio," said Judy Stewart, Senior Vice President and Head of US Vaccines, GSK.

tradermichael
06/6/2022
06:21
Another FDA approval today
ayl30
05/6/2022
20:49
Lol. Fair point net curtains. Indeed I'm not a personal friend of the original Mr Smithskline but a supporter of GSK for the last 20yrs nonetheless.
finctastic
05/6/2022
17:53
Finctastic: you said: "I've held GSK since the start"
That cant be true.
SmithKline was founded in 1830

netcurtains
05/6/2022
16:24
I've held GSk since the start but I'm with Pfizor on this one. Get out and leave the debt if in doubt. Which there definitely is imo.
finctastic
04/6/2022
20:27
Wonder what the float price will be
mj19
03/6/2022
08:35
I generally shun these demergers/consolidations etc. because I need to calculate the book costs for the two entities after selling post corporate action in order to assess capital gains.
tradermichael
02/6/2022
08:14
Looks like Haleon will carry the debt:

Before the demerger, GSK is planning to take a dividend of more than £7bn and Pfizer more than £3bn, leaving Haleon with net debt of £10.3bn, a figure it plans to reduce over time.

tradermichael
01/6/2022
23:02
Don't overlook the tracker funds that will have to own it as a FT 100 share and the only free stock will come from Pfizer for starters
ianood
01/6/2022
18:04
The Pfizer intention has been known for a few months, no surprise ....;0)
tradermichael
01/6/2022
16:15
It looks like renewed weakness in the US markets did for GSK this afternoon.
That plus the Pfizer news - do we think that was priced in or a surprise? I hadn’t heard it before …

spyder
01/6/2022
15:02
Back in the 1600s for the split then
spoole5
01/6/2022
11:40
It is not unresonable to assume that Pfizer and GSK (but especially Pfizer) would not sell shares in Haleon at a market cap of less than £50m or possibly even £60m given that they rejected a bid of £50m and said they wouldn’t sell for less than £60m.
They would look a bit daft if they then cash out at £40m!

spyder
Chat Pages: Latest  1203  1202  1201  1200  1199  1198  1197  1196  1195  1194  1193  1192  Older

Your Recent History

Delayed Upgrade Clock